Most notably, we establish that exposure to the CML microenvironment results in downregulation of cell surface CD36 expression, leading to a functional impairment of macrophage efferocytosis. The gene discussed is CD36; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.